Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Current evidence supporting associations of DNA methylation measurements with survivorship burdens in cancer survivors: A scoping review

Cancer Medicine(2024)10.1002/cam4.7470Source: DataRank Database

Current evidence supporting associations of DNA methylation measurements with survivorship burdens in cancer survivors: A scoping review is a research paper published in Cancer Medicine (2024). On theSindex it has a DataRank of 0. It has been cited 5 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access5 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)Impact (FWCI 0.82)OA: goldTopics (89)IDs (PubMed, PMC, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (5)

Ding Quan Ng ORCID,Raymond J. Chan ORCID,Kord M. Kober ORCID,Alexandre Chan ORCID,M. Sayer ORCID

Live enrichment

PubMed:38963018 PMC:PMC11222976 OpenAlex:https://openalex.org/W4400324524

NCI NIH HHS

Grant: R37 CA233774

National Institutes of Health

Grant: 5R37CA233774-05

An Investigation of the Molecular Mechanisms for and Prediction of the Severity of Cancer Chemotherapy-Related Fatigue Using a Multi-staged Integrated Omics Approach

National Institutes of Health

Grant: 5R01CA276212-02

Neurotrophic strategy to mitigate chemotherapy-related brain injury

FWCI

0.82

Citation Percentile

0.7%

Citation Trend

2024

2025

2026

goldLicense: cc-by

journalhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/cam4.7470

publisherhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/cam4.7470

publisherhttps://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.7470

journalhttps://doi.org/10.1002/cam4.7470

repositoryhttps://pubmed.ncbi.nlm.nih.gov/38963018

Fields of Study

Epigenetics and DNA MethylationCancer survivorship and careChildhood Cancer Survivors' Quality of Life0302 clinical medicine03 medical and health sciences

MeSH Terms

Cancer SurvivorsSurvivorshipFemaleHumansNeoplasmsBiomarkers, TumorDNA MethylationEpigenesis, Genetic

Keywords

dNaMSurvivorship curveCancerCancer survivorConfoundingDNA methylationMedicineCancer survivorshipEpigeneticsOncologyBreast cancerGerontologyDemographyInternal medicineBioinformaticsBiologyGeneticsLiterature reviewStudy DesignMultivariate ModelingEpigenetic AgingDifferential Dna MethylationPrevention (rcdc)Women's Health (rcdc)ReviewSurvivorshipEpigenesis, GeneticClinical Research (rcdc)Cancer SurvivorsCancer Survivors (mesh)Neoplasms32 Biomedical and Clinical Sciences (for-2020)RC254-282PediatricCancer (rcdc)Humans (mesh)Neoplasms (mesh)Tumor3 Good Health and Well Being (sdg)RehabilitationNeoplasms. Tumors. Oncology. Including cancer and carcinogens1112 Oncology and Carcinogenesis (for)Rehabilitation (rcdc)Pediatric Cancer (rcdc)FemaleTumor (mesh)Pediatric CancerOncology and Carcinogenesis0601 Biochemistry and Cell Biology (for)610Rare Diseases (rcdc)Rare DiseasesGeneticClinical Research616Biomarkers, Tumor3211 Oncology and carcinogenesis (for-2020)HumansDNA Methylation (mesh)Pediatric (rcdc)Biomedical and Clinical SciencesGenetics (rcdc)PreventionHuman Genome4.1 Discovery and preclinical testing of markers and technologies (hrcs-rac)Survivorship (mesh)Cancer (hrcs-hc)Human Genome (rcdc)4.1 Discovery and preclinical testing of markers and technologiesGood Health and Well BeingFemale (mesh)Women's HealthGenetic (mesh)Biochemistry and Cell BiologyBiomarkersEpigenesis

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being